TrialDiabetes2025

Effects of Dorzagliatin, a Glucokinase Activator, on α- and β-Cell Function in Individuals With Impaired and Normal Glucose Tolerance.

Zhengli Bai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.